169 related articles for article (PubMed ID: 19387764)
1. Bone fragility in male glucocorticoid-induced osteoporosis is not defined by bone mineral density.
Hayashi K; Yamamoto M; Murakawa Y; Yamauchi M; Kaji H; Yamaguchi T; Sugimoto T
Osteoporos Int; 2009 Nov; 20(11):1889-94. PubMed ID: 19387764
[TBL] [Abstract][Full Text] [Related]
2. Discriminative ability of trabecular bone score over bone mineral density for vertebral and fragility fracture in patients treated with long-term and low-dose glucocorticoid.
Lee KA; Kim J; Kim HJ; Kim HS
Int J Rheum Dis; 2021 Aug; 24(8):1053-1060. PubMed ID: 34184827
[TBL] [Abstract][Full Text] [Related]
3. Fracture risk in oral glucocorticoid users: a Bayesian meta-regression leveraging control arms of osteoporosis clinical trials.
Amiche MA; Albaum JM; Tadrous M; Pechlivanoglou P; Lévesque LE; Adachi JD; Cadarette SM
Osteoporos Int; 2016 May; 27(5):1709-18. PubMed ID: 26694595
[TBL] [Abstract][Full Text] [Related]
4. Dual energy X-ray absorptiometry outcomes in male COPD patients after treatment with different glucocorticoid regimens.
Dubois EF; Röder E; Dekhuijzen PN; Zwinderman AE; Schweitzer DH
Chest; 2002 May; 121(5):1456-63. PubMed ID: 12006428
[TBL] [Abstract][Full Text] [Related]
5. Skeletal findings in the first 12 months following initiation of glucocorticoid therapy for pediatric nephrotic syndrome.
Phan V; Blydt-Hansen T; Feber J; Alos N; Arora S; Atkinson S; Bell L; Clarson C; Couch R; Cummings EA; Filler G; Grant RM; Grimmer J; Hebert D; Lentle B; Ma J; Matzinger M; Midgley J; Pinsk M; Rodd C; Shenouda N; Stein R; Stephure D; Taback S; Williams K; Rauch F; Siminoski K; Ward LM;
Osteoporos Int; 2014 Feb; 25(2):627-37. PubMed ID: 23948876
[TBL] [Abstract][Full Text] [Related]
6. Role of bone mineral density in predicting morphometric vertebral fractures in patients with HIV infection.
Porcelli T; Gotti D; Cristiano A; Maffezzoni F; Mazziotti G; Focà E; Castelli F; Giustina A; Quiros-Roldan E
Osteoporos Int; 2014 Sep; 25(9):2263-9. PubMed ID: 25056799
[TBL] [Abstract][Full Text] [Related]
7. Vertebral bone attenuation on low-dose chest CT: quantitative volumetric analysis for bone fragility assessment.
Kim YW; Kim JH; Yoon SH; Lee JH; Lee CH; Shin CS; Park YS
Osteoporos Int; 2017 Jan; 28(1):329-338. PubMed ID: 27480628
[TBL] [Abstract][Full Text] [Related]
8. The impact of glucocorticoid therapy on trabecular bone score in older women.
Paggiosi MA; Peel NF; Eastell R
Osteoporos Int; 2015 Jun; 26(6):1773-80. PubMed ID: 25743176
[TBL] [Abstract][Full Text] [Related]
9. Influence of recency and duration of glucocorticoid use on bone mineral density and risk of fractures: population-based cohort study.
Majumdar SR; Morin SN; Lix LM; Leslie WD
Osteoporos Int; 2013 Sep; 24(9):2493-8. PubMed ID: 23572142
[TBL] [Abstract][Full Text] [Related]
10. The threshold of bone mineral density for vertebral fracture in female patients with glucocorticoid-induced osteoporosis.
Kaji H; Yamauchi M; Chihara K; Sugimoto T
Endocr J; 2006 Feb; 53(1):27-34. PubMed ID: 16543669
[TBL] [Abstract][Full Text] [Related]
11. Urinary deoxypyridinoline is a BMD-independent marker for prevalent vertebral fractures in postmenopausal women treated with glucocorticoid.
Kaji H; Yamauchi M; Yamaguchi T; Sugimoto T
Osteoporos Int; 2010 Sep; 21(9):1585-90. PubMed ID: 19924495
[TBL] [Abstract][Full Text] [Related]
12. The associations between QCT-based vertebral bone measurements and prevalent vertebral fractures depend on the spinal locations of both bone measurement and fracture.
Anderson DE; Demissie S; Allaire BT; Bruno AG; Kopperdahl DL; Keaveny TM; Kiel DP; Bouxsein ML
Osteoporos Int; 2014 Feb; 25(2):559-66. PubMed ID: 23925651
[TBL] [Abstract][Full Text] [Related]
13. Prevalent vertebral fracture is dominantly associated with spinal microstructural deterioration rather than bone mineral density in patients with type 2 diabetes mellitus.
Yamamoto M; Yamauchi M; Sugimoto T
PLoS One; 2019; 14(9):e0222571. PubMed ID: 31525243
[TBL] [Abstract][Full Text] [Related]
14. Long-term glucocorticoid effect on bone mineral density in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Ceccato F; Barbot M; Albiger N; Zilio M; De Toni P; Luisetto G; Zaninotto M; Greggio NA; Boscaro M; Scaroni C; Camozzi V
Eur J Endocrinol; 2016 Aug; 175(2):101-6. PubMed ID: 27185866
[TBL] [Abstract][Full Text] [Related]
15. Vertebral fracture prevalence among Greek healthy middle-aged postmenopausal women: association with demographics, anthropometric parameters, and bone mineral density.
Lambrinoudaki I; Flokatoula M; Armeni E; Pliatsika P; Augoulea A; Antoniou A; Alexandrou A; Creatsa M; Panoulis C; Dendrinos S; Papacharalambous X
Spine J; 2015 Jan; 15(1):86-94. PubMed ID: 25106754
[TBL] [Abstract][Full Text] [Related]
16. Trabecular bone score improves fracture risk assessment in glucocorticoid-induced osteoporosis.
Florez H; Hernández-Rodríguez J; Muxi A; Carrasco JL; Prieto-González S; Cid MC; Espinosa G; Gómez-Puerta JA; Monegal A; Guañabens N; Peris P
Rheumatology (Oxford); 2020 Jul; 59(7):1574-1580. PubMed ID: 31628810
[TBL] [Abstract][Full Text] [Related]
17. Bone status in glucocorticoid-treated men and women.
Leib ES; Winzenrieth R
Osteoporos Int; 2016 Jan; 27(1):39-48. PubMed ID: 26252975
[TBL] [Abstract][Full Text] [Related]
18. Independent association of bone mineral density and trabecular bone score to vertebral fracture in male subjects with chronic obstructive pulmonary disease.
Watanabe R; Tai N; Hirano J; Ban Y; Inoue D; Okazaki R
Osteoporos Int; 2018 Mar; 29(3):615-623. PubMed ID: 29167970
[TBL] [Abstract][Full Text] [Related]
19. Differences in hip quantitative computed tomography (QCT) measurements of bone mineral density and bone strength between glucocorticoid-treated and glucocorticoid-naive postmenopausal women.
Lian KC; Lang TF; Keyak JH; Modin GW; Rehman Q; Do L; Lane NE
Osteoporos Int; 2005 Jun; 16(6):642-50. PubMed ID: 15455195
[TBL] [Abstract][Full Text] [Related]
20. Plasma leptin concentrations are associated with bone mineral density and the presence of vertebral fractures in postmenopausal women.
Yamauchi M; Sugimoto T; Yamaguchi T; Nakaoka D; Kanzawa M; Yano S; Ozuru R; Sugishita T; Chihara K
Clin Endocrinol (Oxf); 2001 Sep; 55(3):341-7. PubMed ID: 11589677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
